Search by Drug Name or NDC

    NDC 69367-0334-16 WesTussin DM 1; 10; 5 mg/5mL; mg/5mL; mg/5mL Details

    WesTussin DM 1; 10; 5 mg/5mL; mg/5mL; mg/5mL

    WesTussin DM is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Westminster Pharmaceuticals, LLC. The primary component is DEXCHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 69367-0334
    Product ID 69367-334_08a5f7d6-6f1b-4d1c-8f06-1672bda7ea3a
    Associated GPIs 43995803781220
    GCN Sequence Number 078018
    GCN Sequence Number Description dexchlorphen/phenylephrine/DM SYRUP 1-5-10MG/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 44218
    HICL Sequence Number 044697
    HICL Sequence Number Description DEXCHLORPHENIRAMINE MALEATE/PHENYLEPHRINE/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name WesTussin DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name dexchlorpheniramine maleate, dextromethorphan hbr, phenylephrine hcl
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 1; 10; 5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXCHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Westminster Pharmaceuticals, LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 69367-0334-16 (69367033416)

    NDC Package Code 69367-334-16
    Billing NDC 69367033416
    Package 480 mL in 1 BOTTLE, PLASTIC (69367-334-16)
    Marketing Start Date 2021-07-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04407
    Pricing Unit ML
    Effective Date 2023-12-20
    NDC Description WESTUSSIN DM 1-5-10 MG/5 ML SYR
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 68a0cd44-3fdd-430e-af1a-498d4415ab78 Details

    Revised: 8/2021